2cureX AB logo

2CUREX BTA 1 - 2cureX AB Share Price

SEK15.7 0.0  0.0%

Last Trade - 02/07/19

Sector
Healthcare
Size
Micro Cap
Market Cap £13.9m
Enterprise Value £10.8m
Revenue £n/a
Position in Universe th / 1558
Bullish
Bearish
Unlock 2CUREX BTA 1 Revenue
Momentum
Relative Strength (%)
1m
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High
50d MA
200d MA
Margin of Safety
Qualifying GuruScreens
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History

Revenue

2CUREX BTA 1 Revenue Unlock 2CUREX BTA 1 Revenue

Net Income

2CUREX BTA 1 Net Income Unlock 2CUREX BTA 1 Revenue

Normalised EPS

2CUREX BTA 1 Normalised EPS Unlock 2CUREX BTA 1 Revenue

PE Ratio Range

2CUREX BTA 1 PE Ratio Range Unlock 2CUREX BTA 1 Revenue

Dividend Yield Range

2CUREX BTA 1 Dividend Yield Range Unlock 2CUREX BTA 1 Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2019
31st Dec 2020
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2019 /  2020
2CUREX BTA 1 EPS Forecasts Unlock 2CUREX BTA 1 Revenue
Profile Summary

2cureX AB is a Sweden-based company engaged in the biotechnology sector. The Company focuses on the research and development of diagnostic substances to select treatment for cancer patients. The Company's product candidate, IndiTreat - CRC, aims at optimizing medical treatment for the colorectal cancer patients. Through IndiTreat - CRC, healthcare professionals collect a tumor sample from patients to create a number of three-dimensional micro tumors in order to test available chemotherapies and experimental treatments. The Company's product pipeline includes also IndiTreat - OVA, targeting ovarian cancer treatment, and IndiTreat - KDN, focusing on kidney cancer treatment. It operates through 2cureX A/S.

Directors
Last Annual December 31st, 2018
Last Interim September 30th, 2019
Public Since November 24, 2017
No. of Shareholders: n/a
No. of Employees: n/a
Sector Healthcare
Industry Biotechnology & Medical Research
Index
Exchange OMX Nordic Exchange Stockholm (Dual Listing)
Shares in Issue 12,420,000
Free Float (0.0%)
Eligible for
ISAs
SIPPs
Address c/o Mazars SET Revisionsbyra AB Box 159, LANDSKRONA, 261 22, Sweden
Web https://www.2curex.com/
Phone +
Contact ()
Auditors Ohrlings PricewaterhouseCoopers AB
2CUREX BTA 1 Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Similar to 2CUREX BTA 1
© Stockopedia 2019, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.